A Study of the Effectiveness and Safety of Ustekinumab (STELARA) and CNTO 1959 Administered Under the Skin of Patients With Active Rheumatoid Arthritis, Despite Existing Methotrexate Therapy

NCT01645280 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

274

Enrollment

INDUSTRY

Sponsor class

Conditions

Arthritis, Rheumatoid

Interventions

DRUG: Placebo + methotrexate (MTX) (Group 1)
DRUG: Ustekinumab + MTX (Group 2)
DRUG: Ustekinumab + MTX (Group 3)
DRUG: CNTO 1959 + MTX (Group 4)
DRUG: CNTO 1959 + MTX (Group 5)

Sponsor

Janssen Research & Development, LLC